These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29558971)

  • 21. Advances in Circulating Tumor DNA Analysis.
    Perakis S; Auer M; Belic J; Heitzer E
    Adv Clin Chem; 2017; 80():73-153. PubMed ID: 28431643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
    Pi C; Zhang MF; Peng XX; Zhang YC; Xu CR; Zhou Q
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1089-1096. PubMed ID: 29057681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and future perspectives of liquid biopsies in genomics-driven oncology.
    Heitzer E; Haque IS; Roberts CES; Speicher MR
    Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer.
    Schøler LV; Reinert T; Ørntoft MW; Kassentoft CG; Árnadóttir SS; Vang S; Nordentoft I; Knudsen M; Lamy P; Andreasen D; Mortensen FV; Knudsen AR; Stribolt K; Sivesgaard K; Mouritzen P; Nielsen HJ; Laurberg S; Ørntoft TF; Andersen CL
    Clin Cancer Res; 2017 Sep; 23(18):5437-5445. PubMed ID: 28600478
    [No Abstract]   [Full Text] [Related]  

  • 25. Liquid biopsy for rectal cancer: A systematic review.
    Massihnia D; Pizzutilo EG; Amatu A; Tosi F; Ghezzi S; Bencardino K; Di Masi P; Righetti E; Patelli G; Scaglione F; Vanzulli A; Siena S; Sartore-Bianchi A
    Cancer Treat Rev; 2019 Sep; 79():101893. PubMed ID: 31499407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
    Nordgård O; Tjensvoll K; Gilje B; Søreide K
    Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.
    Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y
    Theranostics; 2019; 9(14):4130-4140. PubMed ID: 31281536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
    Takai E; Yachida S
    World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress of Liquid Biopsy in Early Diagnosis of Lung Cancer].
    Song Z; Liu Y
    Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):620-627. PubMed ID: 30172270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
    Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
    Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivering on the promise of early detection with liquid biopsies.
    Crosby D
    Br J Cancer; 2022 Feb; 126(3):313-315. PubMed ID: 35013576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers].
    Perrier A; Hainaut P; Guenoun A; Nguyen DP; Lamy PJ; Guerber F; Troalen F; Denis JA; Boissan M
    Bull Cancer; 2022 Feb; 109(2):170-184. PubMed ID: 35034786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
    Theil G; Fornara P
    Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementing circulating tumor DNA analysis in a clinical laboratory: A user manual.
    Koessler T; Addeo A; Nouspikel T
    Adv Clin Chem; 2019; 89():131-188. PubMed ID: 30797468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid Biopsy Applications in the Clinic.
    Chen D; Xu T; Wang S; Chang H; Yu T; Zhu Y; Chen J
    Mol Diagn Ther; 2020 Apr; 24(2):125-132. PubMed ID: 31919754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid biopsies in gastrointestinal malignancies: when is the big day?
    Lopez A; Harada K; Mizrak Kaya D; Dong X; Song S; Ajani JA
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):19-38. PubMed ID: 29202614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid Biopsy: From Discovery to Clinical Application.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2021 Apr; 11(4):858-873. PubMed ID: 33811121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cancer bloodhounds.
    Webb S
    Nat Biotechnol; 2016 Nov; 34(11):1090-1094. PubMed ID: 27824838
    [No Abstract]   [Full Text] [Related]  

  • 40. Somatic copy number aberrations in metastatic patients: The promise of liquid biopsies.
    Baldacchino S; Grech G
    Semin Cancer Biol; 2020 Feb; 60():302-310. PubMed ID: 31891778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.